CCL21 and breast cancer: Expression of the CCL21 receptor CCR7 is also increased in breast cancer cells upon TGF‐β‐induced EMT, which facilitates breast cancer cell migration toward CCL21‐positive, draining lymphatic vessels in mice, in a DC‐like fashion (Pang et al., 2016).